基于“阳气化行”理论探析心肌梗死后心力衰竭的诊治思路
Post-Myocardial Infarction Heart Failure: Diagnostic and Therapeutic Insights from the Perspective of Yang Qi Transformation and Circulation Theory
DOI: 10.12677/tcm.2025.1410611, PDF,   
作者: 朱艺炎:天津中医药大学第一附属医院心血管科,国家中医针灸临床医学研究中心,天津;天津中医药大学研究生院,天津;赵桂峰*:天津中医药大学第一附属医院心血管科,国家中医针灸临床医学研究中心,天津
关键词: 心梗后心衰阳气化行阳虚温阳化气化瘀利水Yang Qi Transformation and Circulation Heart Failure after Acute Myocardial Infarction Yang Asthenia Wenyang Huaqi Removing Blood Stasis and Water
摘要: 急性心肌梗死后心力衰竭(心梗后心衰)是急性心肌梗死患者最常见且严重的并发症之一,且发病率高、预后差,严重威胁患者生命安全。“阳气化行”理论源于《周易》乾坤学说,承《内经》“阳气者,若天与日”之旨,经张仲景扶阳思想发展,至郑钦安而集大成。本文旨在构建基于“阳气化行”理论的心梗后心衰中医病机理论框架,为临床辨证论治提供系统性指导。心梗后心衰的发生发展与“阳气化行”理论密切相关,阳气卫外失司,营卫不和,腠理疏松,外邪乘虚而入,损伤心体,此为发病之始动因素;阳气推动无力,血行瘀滞,津液输布失常,痰瘀胶结,阻滞心络,此为发病之关键病理环节;心阳亏虚,一身阳气失其根本,日久累计脾肾,脾失温煦而运化失司,肾失资助而气化不行,水湿痰浊内生,此为发病之根本。本文以“阳气化行”理论为指导,秉承“未病先防”、“既病防变”理念,以益气温阳为主要治法,兼以调和营卫、活血通络、化饮利水,从根本上恢复阳气化行功能,达到“阳气化行,阴邪即灭”之治疗目标。
Abstract: Post-myocardial infarction heart failure (post-MI heart failure) is one of the most common and severe complications in patients with acute myocardial infarction, characterized by high incidence and poor prognosis, posing a serious threat to patients’ life safety. The theory of “Yang Qi transformation and circulation” originated from the Qian-Kun doctrine in the Book of Changes (I Ching), inherited the essence of “Yang Qi is like heaven and sun” from the Neijing (Inner Canon), developed through Zhang Zhongjing’s Yang-supporting theory, and reached its culmination with Zheng Qin’an. The occurrence and development of post-MI heart failure are closely related to the theory of “Yang Qi transformation and circulation.” The dysfunction of Yang Qi’s defensive function leads to disharmony between nutrient Qi and defensive Qi, loose interstices, and external pathogens invading due to deficiency, thereby damaging the heart substance—this constitutes the initiating factor of pathogenesis. The weakened propelling function of Yang Qi results in blood stasis, abnormal distribution of body fluid, phlegm-stasis binding, and blockage of heart collaterals—this represents the key pathological process of pathogenesis. Heart Yang deficiency causes the loss of the root of whole-body Yang Qi, which gradually affects the spleen and kidney over time: the spleen loses warmth and fails in transportation, while the kidney loses support and fails in Qi transformation, leading to internal generation of water-dampness and phlegm-turbidity—this constitutes the fundamental pathogenesis. This article, guided by the theory of “Yang Qi transformation and circulation” and adhering to the concepts of “preventing disease before onset” and “preventing transmission after onset,” employs supplementing Qi and warming Yang as the primary therapeutic method, combined with harmonizing nutrient and defensive Qi, activating blood and unblocking collaterals, and resolving fluid retention and promoting urination. The treatment aims to fundamentally restore the function of Yang Qi transformation and circulation, achieving the therapeutic goal of “when Yang Qi transforms and circulates, pathogenic Yin is eliminated”.
文章引用:朱艺炎, 赵桂峰. 基于“阳气化行”理论探析心肌梗死后心力衰竭的诊治思路[J]. 中医学, 2025, 14(10): 4210-4216. https://doi.org/10.12677/tcm.2025.1410611

参考文献

[1] 中国医师协会心血管内科医师分会、中国心血管健康联盟·心肌梗死专家共识工作组. 2020心肌梗死后心力衰竭防治专家共识[J]. 中国循环杂志, 2020, 35(12): 1166-1180.
[2] 《中国心血管健康与疾病报告2021》要点解读[J]. 中国心血管杂志, 2022, 27(4): 305-318.
[3] 管慧, 戴国华, 高武霖, 等. 中医药干预急性心肌梗死并发心力衰竭患者终点事件发生的队列研究[J]. 世界中医药, 2021, 16(23): 3553-3556.
[4] 卫靖靖, 朱正望, 彭广操, 等. 基于数据挖掘探究中药治疗心肌梗死后心力衰竭的用药规律[J]. 中国中药杂志, 2022, 47(20): 5654-5661.
[5] 郑钦安, 唐步祺, 阐. 医理真传[M]. 成都: 巴蜀书社, 1989.
[6] 麦舒桃, 邹旭. 《内经》阳气理论探析[J]. 四川中医, 2008(6): 33-34.
[7] 王兆博. 新环境下胸痹(冠心病)中医证素、证型分布及特点分析研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2018.
[8] 刘龙涛, 陈可冀, 付长庚, 等. 从“因瘀致毒”谈冠心病的病因病机[J]. 中国中西医结合杂志, 2015, 35(11): 1378-1380.
[9] 钟燕, 王振兴. 中医药治疗心肌梗死后心力衰竭的研究进展[J]. 基层中医药, 2024, 3(2): 119-124.
[10] 常成成, 魏聪, 吴以岭. 脉络学说“孙络-微血管”概念及其临床指导意义[J]. 中医杂志, 2016, 57(1): 7-11.
[11] 常成成, 李红蓉, 刘红利, 等. 脉络学说营卫交会生化理论探讨[J]. 中医杂志, 2017, 58(1): 2-5.
[12] 张欣媛, 熊鑫, 韩金霞, 等. 黄芪甲苷对心衰模型大鼠心肌炎性因子和MAPK信号通路的影响[J]. 中医药学报, 2023, 51(1): 30-35.
[13] 李梦华. 黄芪甲苷在心肌梗死大鼠模型中的心肌保护作用[J]. 科学技术与工程, 2021, 21(9): 3520-3525.
[14] 张现芳, 王立波. 桂枝汤加味配合西药治疗慢性心力衰竭临床观察[J]. 中医临床研究, 2019, 11(6): 44.
[15] 杨金龙, 刘昕烨, 李晓. 参芪营心饮治疗慢性心力衰竭心脏自主神经病变的疗效观察[J]. 中国中西医结合杂志, 2017, 37(2): 247-249.
[16] 秘红英, 宋红霞, 李雅文, 等. 通心络胶囊治疗心肌梗死后心力衰竭的研究进展[J]. 天津中医药, 2020, 37(9): 1076-1080.
[17] 张丞波, 张苏洁, 杨月东, 等. 益气活血方对急性ST段抬高型心肌梗死后心力衰竭患者心肌纤维化的影响[J]. 南京中医药大学学报, 2023, 39(2): 111-117.
[18] 闫安平. 血府逐瘀汤加味治疗急性心肌梗死经皮冠状动脉介入治疗术后气滞血瘀型心衰临床观察[J]. 山西中医, 2021, 37(9): 34-35.
[19] 庄丽, 葛毅骏, 弥守玲, 等. 枳实薤白桂枝汤治疗冠心病合并心衰的临床疗效观察[J/OL]. 辽宁中医药大学学报, 1-9.
https://link.cnki.net/urlid/21.1543.R.20250718.1757.004, 2025-10-01.
[20] 孙玉涛. 枳实薤白桂枝汤联合阿托伐他汀对急性心肌梗死患者心功能、血脂水平及hs-CRP的影响[J]. 国医论坛, 2018, 33(3): 40-41.
[21] 陈伟, 覃仕化. 保元汤合枳实薤白桂枝汤加减治疗中-重度气虚血瘀型慢性心衰的临床疗效观察[J]. 心血管病防治知识(学术版), 2019, 9(32): 39-40.
[22] 樊讯. 《伤寒论》温阳三方干预心梗后心衰心阳虚证候大鼠心室重构的比较研究[D]: [博士学位论文]. 武汉: 湖北中医药大学, 2011.
[23] 李向阳, 姚娟, 汤同娟, 等. 苓桂术甘汤对心梗后慢性心衰模型大鼠心肌纤维化及心肌组织Wnt1/β-catenin信号通路蛋白表达的影响[J]. 中药材, 2023, 46(6): 1501-1506.
[24] 余思仪. 苓桂术甘汤通过干预线粒体改善心肌梗死后慢性心衰大鼠心功能[D]: [硕士学位论文]. 十堰: 湖北医药学院, 2022.
[25] 周蔓菁, 唐其柱. 真武汤对老年慢性心力衰竭患者血流动力学、MMP-9和心功能的影响[J]. 世界中医药, 2019, 14(4): 926-930.